Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |